Chemotherapy for malignant pleural mesothelioma: past results and recent developments
Open Access
- 1 August 2004
- journal article
- review article
- Published by Elsevier in Lung Cancer
- Vol. 45 (2) , S103-S119
- https://doi.org/10.1016/j.lungcan.2004.04.020
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Current phase II data for ZD0473 in patients with mesothelioma who had relapsed following one prior chemotherapy regimenEuropean Journal Of Cancer, 2001
- Phase II study of ALIMTA (pemetrexed disodium, MTA) single agent in patients with malignant pleural mesotheliomaEuropean Journal Of Cancer, 2001
- Combination raltitrexed (Tomudex®)–oxaliplatin: a step forward in the struggle against mesothelioma? The Institut Gustave Roussy experience with chemotherapy and chemo-immunotherapy in mesotheliomaEuropean Journal Of Cancer, 2000
- Edatrexate (10‐ethyl‐deaza‐aminopterin) (NSC #626715) with or without leucovorin rescue for malignant mesotheliomaCancer, 1999
- Ifosfamide in malignant mesothelioma: a phase II studyLung Cancer, 1999
- Higher doses of α-interferon do not increase the activity of the weekly cisplatin-interferon combination in advanced malignant mesotheliomaEuropean Journal Of Cancer, 1997
- Two dose levels of ifosfamide in malignant mesotheliomaLung Cancer, 1996
- Mitoxantrone in malignant pleural mesothelioma: A study by the EORTC lung cancer cooperative groupEuropean Journal of Cancer and Clinical Oncology, 1991
- A phase II trial of ifosfamide/mesna with doxorubicin for malignant mesotheliomaEuropean Journal of Cancer and Clinical Oncology, 1989
- The Pathogenesis of Asbestos-Associated DiseasesNew England Journal of Medicine, 1982